John Lister

10.1k total citations · 1 hit paper
178 papers, 7.2k citations indexed

About

John Lister is a scholar working on Hematology, Oncology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, John Lister has authored 178 papers receiving a total of 7.2k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Hematology, 44 papers in Oncology and 41 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in John Lister's work include Cardiac Arrhythmias and Treatments (31 papers), Lymphoma Diagnosis and Treatment (30 papers) and Cardiac pacing and defibrillation studies (25 papers). John Lister is often cited by papers focused on Cardiac Arrhythmias and Treatments (31 papers), Lymphoma Diagnosis and Treatment (30 papers) and Cardiac pacing and defibrillation studies (25 papers). John Lister collaborates with scholars based in United States, United Kingdom and Canada. John Lister's co-authors include Richard K. Shadduck, Diying Shen, A.J. Grillo-López, Michael E. Williams, Ronald Levy, B.K. Dallaire, Isabelle Bence‐Bruckler, M. S. Czuczman, Meyer R. Heyman and Vinay Jain and has published in prestigious journals such as Science, New England Journal of Medicine and The Lancet.

In The Last Decade

John Lister

167 papers receiving 6.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program.

1998 2.2k citations Peter McLaughlin, A.J. Grillo-López et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
John Lister United States	39	2.0k	1.6k	1.2k	1.2k	1.1k	178	7.2k
Jean‐Charles Piette France	69	1.4k 0.7×	1.2k 0.7×	1.1k 0.9×	738 0.6×	2.9k 2.5×	201	14.1k
Giorgina Specchia Italy	48	1.2k 0.6×	2.0k 1.3×	2.3k 1.9×	1.7k 1.5×	1.1k 1.0×	401	10.4k
Carlomaurizio Montecucco Italy	54	1.4k 0.7×	799 0.5×	1.0k 0.8×	361 0.3×	2.3k 2.0×	436	9.9k
James L. Zehnder United States	47	1.4k 0.7×	1.6k 1.0×	1.8k 1.5×	432 0.4×	1.4k 1.2×	231	8.4k
Tore Saxne Sweden	59	905 0.5×	1.1k 0.7×	760 0.6×	403 0.3×	2.8k 2.5×	202	12.1k
Matthew D. Griffin United States	61	1.2k 0.6×	1.5k 0.9×	2.0k 1.6×	775 0.7×	2.8k 2.5×	204	12.7k
Roberto Gerli Italy	52	890 0.4×	918 0.6×	499 0.4×	434 0.4×	2.7k 2.4×	267	8.0k
Zahir Amoura France	75	1.8k 0.9×	1.4k 0.9×	1.1k 0.9×	548 0.5×	6.3k 5.5×	424	17.6k
Joachim R. Kalden Germany	45	1.3k 0.7×	1.2k 0.8×	1.5k 1.2×	318 0.3×	4.4k 3.9×	163	13.4k
E. William St. Clair United States	55	1.7k 0.8×	1.2k 0.7×	2.3k 1.9×	392 0.3×	5.3k 4.7×	170	16.5k

Countries citing papers authored by John Lister

Since Specialization

Citations

This map shows the geographic impact of John Lister's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Lister with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Lister more than expected).

Fields of papers citing papers by John Lister

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Lister. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Lister. The network helps show where John Lister may publish in the future.

Co-authorship network of co-authors of John Lister

This figure shows the co-authorship network connecting the top 25 collaborators of John Lister. A scholar is included among the top collaborators of John Lister based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Lister. John Lister is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kang, Bum‐Yong, Jiwoong Choi, Victor Tseng, et al.. (2025). USP11 Promotes Endothelial Apoptosis-Resistance in Pulmonary Arterial Hypertension by Deubiquitinating HINT3. PubMed. 2(1). 10002–10002.

Donnenberg, Vera S., et al.. (2025). Fast tumor-infiltrating lymphocytes (TILs): rapid manufacture of an adoptive cellular therapeutic from pleural infiltrating T cells for intrapleural administration. Cytotherapy. 27(11). 1279–1289. 1 indexed citations

Khattab, Ahmed, et al.. (2023). Donor Cell Leukemia Following Allogeneic Hematopoietic Stem Cell Transplantation. Journal of Hematology. 12(3). 138–144.

Jayakrishnan, Thejus, et al.. (2023). Treatment Selection and Survival in Patients with Gray Zone Lymphoma: A Comprehensive Population-Based Analysis. Hematology/Oncology and Stem Cell Therapy. 16(3). 245–253.

Jayakrishnan, Thejus, et al.. (2020). Disparities in the enrollment to systemic therapy and survival for patients with multiple myeloma ☆. Hematology/Oncology and Stem Cell Therapy. 14(3). 218–230. 10 indexed citations

Gilmore, Gary L., et al.. (2008). Fetal-maternal microchimerism in normal parous females and parous female cancer patients. Experimental Hematology. 36(9). 1073–1077. 40 indexed citations

Lister, John, Jeffrey Gryn, Karina L. McQueen, et al.. (2007). Multiple Unit HLA-Unmatched Sex-Mismatched Umbilical Cord Blood Transplantation for Advanced Hematological Malignancy. Stem Cells and Development. 16(1). 177–186. 13 indexed citations

Gryn, Jeffrey, Richard K. Shadduck, John Lister, Zella R. Zeigler, & Jane M. Raymond. (2002). Factors Affecting Purification of CD34 ⁺ Peripheral Blood Stem Cells Using the Baxter Isolex 300i. Journal of Hematotherapy & Stem Cell Research. 11(4). 719–730. 13 indexed citations

Magalhaes‐Silverman, Margarida, Albert D. Donnenberg, John Lister, et al.. (1999). Factors Influencing Mobilization and Engraftment in Patients with Metastatic Breast Cancer Undergoing PBSC Transplantation. Journal of Hematotherapy. 8(2). 167–172. 2 indexed citations

10.

McLaughlin, Peter, A.J. Grillo-López, Brian K. Link, et al.. (1998). Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program.. Journal of Clinical Oncology. 16(8). 2825–2833. 2153 indexed citations breakdown →

11.

Lembersky, Barry C., et al.. (1998). High-dose chemotherapy and autologous stem cell support followed by post-transplant doxorubicin and taxol as initial therapy for metastatic breast cancer: hematopoietic tolerance and efficacy. Bone Marrow Transplantation. 21(12). 1207–1211. 9 indexed citations

12.

Zeigler, Zella R., John Lister, Jane M. Raymond, et al.. (1998). Plasminogen activator inhibitor (PAI-1) antigen levels in primary TTP and secondary TTP post-bone marrow transplantation. American Journal of Hematology. 59(1). 9–14. 19 indexed citations

13.

Neudorf, Steven, Witold B. Rybka, Edward D. Ball, et al.. (1997). The Use of Counterflow Centrifugal Elutriation for the Depletion of T Cells from Unrelated Donor Bone Marrow. Journal of Hematotherapy. 6(4). 351–359. 4 indexed citations

14.

Lister, John, et al.. (1997). Busulfan and cyclophosphamide (BU/CY2) as preparative regimen for patients with lymphoma. Bone Marrow Transplantation. 19(8). 777–781. 23 indexed citations

15.

Erlich, Rodrigo, Steven H. Swerdlow, Naresh Gupta, & John Lister. (1996). Primary Lymphoma of the Skull Presenting as Multiple Cranial Nerve Palsies. Leukemia & lymphoma. 23(3-4). 395–399. 13 indexed citations

16.

Magalhaes‐Silverman, Margarida, Witold B. Rybka, Barry C. Lembersky, et al.. (1996). High-Dose Cyclophosphamide, Carboplatin, and Etoposide with Autologous Stem Cell Rescue in Patients with Breast Cancer. American Journal of Clinical Oncology. 19(2). 169–173. 7 indexed citations

17.

Nogami, Akihiko, John J. Rozanski, Tetsushi Furukawa, Arthur J. Gosselin, & John Lister. (1989). Triphasic time dependence of prognostic markers in patients with sustained ventricular tachyarrhythmias and coronary artery disease.. Japanese Circulation Journal. 53(9). 1061–1071. 1 indexed citations

18.

Gorsuch, A N, B.M. Dean, G. F. Bottazzo, John Lister, & A G Cudworth. (1980). Evidence that type I diabetes and thyrogastric autoimmunity have different genetic determinants.. BMJ. 280(6208). 145–147. 38 indexed citations

19.

Hamilton, D., et al.. (1976). Mode of presentation of juvenile diabetes.. BMJ. 2(6029). 211–212. 31 indexed citations

20.

Lister, John, et al.. (1951). CHARCOT JOINTS IN DIABETIC NEUROPATHY. The Lancet. 258(6694). 1110–1113. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact